Degarelix injections for the treatment of prostate cancer

Description

In this Product Explainer Urologist Prof Henry Woo explains the role of degarelix injections as part of the management of locally advanced or metastatic prostate cancer (3 mins).

Prof Henry Woo

expert

Prof Henry Woo

Urological Surgeon; Professor of Surgery and Discipline of Surgery, Head, Sydney Adventist Hospital Clinical School, University of Sydney; Director, Uro-Oncology, Professor, Robotic Cancer Surgery, Chris O’Brien Lifehouse

Date published: 26 September 2022